Eagle Pharmaceuticals Price on August 28, 2024

EGRXDelisted Stock  USD 1.99  0.02  1.02%   
If you're considering investing in Eagle Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Eagle Pharmaceuticals stands at 1.99, as last reported on the 1st of December, with the highest price reaching 2.40 and the lowest price hitting 1.93 during the day. Eagle Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.33, which denotes the company had a -0.33% return per unit of risk over the last 3 months. Eagle Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eagle Pharmaceuticals' Variance of 45.47, standard deviation of 6.74, and Mean Deviation of 3.94 to check the risk estimate we provide.
  
Eagle Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.3303

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsEGRX

Estimated Market Risk

 9.03
  actual daily
80
80% of assets are less volatile

Expected Return

 -2.98
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.33
  actual daily
0
Most of other assets perform better
Based on monthly moving average Eagle Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eagle Pharmaceuticals by adding Eagle Pharmaceuticals to a well-diversified portfolio.

Eagle Pharmaceuticals Valuation on August 28, 2024

It is possible to determine the worth of Eagle Pharmaceuticals on a given historical date. On August 28, 2024 Eagle was worth 4.65 at the beginning of the trading date compared to the closed value of 5.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eagle Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Eagle Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eagle Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eagle Pharmaceuticals' related companies.
 Open High Low Close Volume
  4.75    4.79    4.59    4.76    46,476  
08/28/2024
  4.65    5.20    4.65    5.20    104,703  
  5.20    5.45    5.14    5.24    79,519  
Backtest Eagle Pharmaceuticals  |  Eagle Pharmaceuticals History  |  Eagle Pharmaceuticals Valuation   PreviousNext  
Open Value
4.65
5.2
Closing Value
31.74
Upside

Eagle Pharmaceuticals Trading Date Momentum on August 28, 2024

On August 29 2024 Eagle Pharmaceuticals was traded for  5.24  at the closing time. The top price for the day was 5.45  and the lowest listed price was  5.14 . The trading volume for the day was 79.5 K. The trading history from August 29, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 0.77% . The overall trading delta against the current closing price is 17.69% .

Eagle Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Eagle Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eagle Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eagle financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Eagle Pharmaceuticals Pink Sheet history

Eagle Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eagle is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eagle Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eagle Pharmaceuticals stock prices may prove useful in developing a viable investing in Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey. Eagle Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

Eagle Pharmaceuticals Pink Sheet Technical Analysis

Eagle Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Eagle Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eagle Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Eagle Pharmaceuticals Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Eagle Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Eagle Pharmaceuticals December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Eagle Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eagle Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eagle Pharmaceuticals pink sheet market strength indicators, traders can identify Eagle Pharmaceuticals entry and exit signals to maximize returns

Eagle Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Eagle Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eagle Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eagle to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Eagle Pink Sheet

If you are still planning to invest in Eagle Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eagle Pharmaceuticals' history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges